Allena Pharmaceuticals Inc (fka ALNAQ)

[Cosa]

I sold another 50% of my holdings today. Still looking to increase my position at a lower sp.

[Cosa]

The most recent news is a loan with convertible rate at like $4.00 a share and new board member.

[John15]

Does anyone know why this has been ticking up past several days? I don't see any news.

[beambe]

good NEWS

[beambe]

Patience

[Cosa]

SP rising pretty high on low volume. I trimmed %50 of my position. If it drops back down in a few days/weeks I will buy all shares back and more. Trying to build a huge position here.

[Cosa]

Nice bump up from a loan. The good thing is it has conversion price of $4.10.

[ClayTrader]

* * $ALNA Video Chart 09-30-2020 * *

Link to Video - click here to watch the technical chart video

[beambe]

good Volume

[Cosa]

Here are some key dates

Reloxaliase: Reloxaliase is a first-in-class, non-absorbed, orally administered enzyme for the treatment of severe hyperoxaluria. Allena is currently evaluating reloxaliase for patients with enteric hyperoxaluria (EH) in URIROX-2, the second pivotal Phase 3 clinical trial in its URIROX program. Allena is actively expanding to new sites and new geographies in its ongoing URIROX-2 clinical trial. The Company continues to expect the interim analysis in the first quarter of 2022 and to announce topline data supporting a potential Biologics License Application (BLA) submission in the third quarter of 2022.

Allena continues to engage with the U.S. Food and Drug Administration (FDA) to explore potential expedited registration paths for reloxaliase in patients with EH and advanced chronic kidney disease (CKD).

ALLN-346: ALLN-346 is a first-in-class, orally administered, novel urate degrading enzyme that has been designed for activity and stability in the gastrointestinal tract for the treatment of hyperuricemia in patients with gout in the setting of advanced CKD. In July 2020, Allena initiated a Phase 1 clinical trial of ALLN-346. Initial data is expected in the fourth quarter of 2020.

[Cosa]

Added more $1.15

[Cosa]

Added more at $1.34

[Cosa]

Added more shares at $1.31 yesterday. Now the patient part begins...wait, wait, and wait.

[Cosa]

efficacy of phase 3 will make this take off, no article needed. Just need to sit, wait, and be patient. If they have good results this could be 10 bagger easy.

[makingitnow]

yeah, needs another article. no support near the current price

[Cosa]

I just opened here at $1.22. Nothing really holding this up, will buy more if it hits $0.95.

[Cosa]

It look like it really took off after this article on July 15
https://finance.yahoo.com/news/3-strong-buy-penny-stocks-192736548.html

[Cosa]

Looking to open a position soon.

[Cosa]

This is another BioPharm lotto that could pay off big. I'll take a position here when it dips lower. That article really pumped the share price up.

[makingitnow]

took position today off my scanner. news? where is the news?
thanks

[crudeoil24]

On its way!

[wesley_]

$2.22 nice

[dinogreeves]

Price target of 10 dollars will be reached by mid next week, reasonable cash on hand. Presentation for kidney disorder is only few hours away, once that data is revealed this could jump to 6 dollars instantly with volume.

[dinogreeves]

ALNA has presentation today in a few hours, could hit 6-8 dollars tomorrow.

[mick]

Allena Pharmaceuticals to Present at Evercore ISI 2nd Annual HEALTHCONx Conference GlobeNewswire Inc. - 11/25/2019 8:00:10 AM

[mick]

Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2019 8:12:37 AM

[mick]

Current Report Filing (8-k) Edgar (US Regulatory) - 11/13/2019 8:01:22 AM

[mick]

Allena Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update GlobeNewswire Inc. - 11/13/2019 8:01:00 AM

[mick]

Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2019 8:20:19 AM

[mick]

Allena Pharmaceuticals Reports Positive Reloxaliase Topline Results from URIROX-1 Trial and from Study 206 GlobeNewswire Inc. - 11/7/2019 6:55:00 AM

[mick]

what an a.h. charge/\

[mick]

Allena Pharmaceutica (ALNA)
2.42 ? 0.21 (9.50%)
Volume: 434,065 @12/02/19 4:26:27 PM EST
Bid Ask Day's Range
2.45 2.48 2.16 - 2.44
ALNA Detailed Quote